InvestorInvesting in a sustainable future.

HBM Partners AG is a Swiss healthcare investor founded in 2001, focusing on venture, growth, and buy-out investments in biopharma, medtech, diagnostics, and healthcare sectors. The firm operates primarily in Europe and North America, with a global investment strategy.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
HBM Partners AG, founded in 2001 and based in Zurich, Switzerland, is a prominent healthcare investor with over $2.5 billion in assets under management. The firm specializes in venture, growth, and buy-out financings, targeting both private and public companies in the biopharma, medtech, diagnostics, and healthcare sectors. HBM Partners has a strong track record, having completed over 100 investments that led to more than 60 trade sales and IPOs. The organization is regulated by FINMA and operates with a team of over 20 experienced investment professionals, focusing on supporting the growth of portfolio companies across various stages of development. HBM Partners is also publicly listed on the SIX Swiss Exchange under HBM Healthcare Investments (HBMN), providing liquidity for its investors.
HBM Partners invests in the biopharma, medtech, diagnostics, and healthcare sectors, engaging in venture, growth, and buy-out financings. Investment amounts typically range from USD 5 to 50 million, with a strategy that includes both private and public healthcare investments.
HBM Partners supports the growth of portfolio companies through various stages of development, leveraging its expertise in the healthcare sector.
HBM Partners focuses on the biopharma, medtech, diagnostics, and healthcare sectors, investing in companies at various stages, primarily later-stage. They typically invest between USD 5 million and 50 million.
Startups interested in pitching to HBM Partners can visit their website at hbmpartners.com for more information on the application process.
HBM Partners is unique due to its focus on healthcare investments and its regulatory status as a FINMA-regulated entity. They also operate as a publicly traded investment company, providing liquidity for investors.
The firm primarily invests in North America and Europe, while also exploring opportunities in emerging markets such as India and China.
HBM Partners adds value to its portfolio companies by providing strategic guidance, operational support, and facilitating access to capital through both private and public markets.
HBM Partners typically invests between USD 5 million and 50 million in their portfolio companies, focusing on substantial growth potential.
Superscout Pro
Is this page right?Reviewed · How the research works